Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Productivity Costs in Economic Evaluations: Past, Present, FuturePharmacoEconomics, 2013-07, Vol.31 (7), p.537-549 [Peer Reviewed Journal]Springer International Publishing Switzerland 2013 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Copyright Wolters Kluwer Health Adis International Jul 2013 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-013-0056-3 ;PMID: 23620213Full text available |
|
2 |
Material Type: Article
|
Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User’s GuidePharmacoEconomics, 2008, Vol.26 (8), p.661-677 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826080-00004 ;PMID: 18620460Full text available |
|
3 |
Material Type: Article
|
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)PharmacoEconomics, 2020-11, Vol.38 (11), p.1219-1236 [Peer Reviewed Journal]The Author(s) 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Nov 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00952-0 ;PMID: 32812149Full text available |
|
4 |
Material Type: Article
|
Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010PharmacoEconomics, 2014-04, Vol.32 (4), p.367-375 [Peer Reviewed Journal]The Author(s) 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0136-z ;PMID: 24477679Full text available |
|
5 |
Material Type: Article
|
Comment on Keeney et al.'s "Delphi Analysis of Relevant Comparators in a Cost‑Effectiveness Model of Prostate Cancer Screening"/ResponsePharmacoEconomics, 2021-08, Vol.39 (8), p.965-970 [Peer Reviewed Journal]Copyright Springer Nature B.V. Aug 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01061-2Full text available |
|
6 |
Material Type: Article
|
How to Estimate Productivity Costs in Economic EvaluationsPharmacoEconomics, 2014-04, Vol.32 (4), p.335-344 [Peer Reviewed Journal]Springer International Publishing Switzerland 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0132-3 ;PMID: 24504850Full text available |
|
7 |
Material Type: Article
|
Economic Implications of Endometriosis: A ReviewPharmacoEconomics, 2022-12, Vol.40 (12), p.1143-1158 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. ;COPYRIGHT 2022 Springer ;Copyright Springer Nature B.V. Dec 2022 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01211-0 ;PMID: 36344867Full text available |
|
8 |
Material Type: Article
|
Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018PharmacoEconomics, 2020-10, Vol.38 (10), p.1135-1145 [Peer Reviewed Journal]The Author(s) 2020. corrected publication 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Oct 2020 ;The Author(s) 2020, corrected publication 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00942-2 ;PMID: 32696192Full text available |
|
9 |
Material Type: Article
|
Health Economics Research on Non-surgical Biomedical HIV Prevention: Identifying Gaps and Proposing a Way ForwardPharmacoEconomics, 2023-07, Vol.41 (7), p.787-802 [Peer Reviewed Journal]The Author(s) 2023 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01231-wDigital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled TrialsPharmacoEconomics, 2014-12, Vol.32 (12), p.1157-1170 [Peer Reviewed Journal]The Author(s) 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;Copyright Springer Science & Business Media Dec 2014 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-014-0193-3 ;PMID: 25069632Full text available |
|
11 |
Material Type: Article
|
Costeffectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment ArrangementPharmacoEconomics, 2023-02, Vol.41 (2), p.175-186 [Peer Reviewed Journal]Copyright Springer Nature B.V. Feb 2023 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-022-01188-wFull text available |
|
12 |
Material Type: Article
|
Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic ReviewPharmacoEconomics, 2018-10, Vol.36 (10), p.1165-1200 [Peer Reviewed Journal]Springer International Publishing AG, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. Oct 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-018-0668-8 ;PMID: 29869050Full text available |
|
13 |
Material Type: Article
|
The Cost‑Effectiveness of Lorlatinib Versus Chemotherapy as a Secondor Third‑Line Treatment in Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑small‑cell Lung Cancer in SwedenPharmacoEconomics, 2021-08, Vol.39 (8), p.941-952 [Peer Reviewed Journal]Copyright Springer Nature B.V. Aug 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01015-8Full text available |
|
14 |
Material Type: Article
|
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and AssessmentPharmacoEconomics, 2021-11, Vol.39 (11), p.1243-1269 [Peer Reviewed Journal]The Author(s) 2021. corrected publication 2021 ;2021. The Author(s). ;COPYRIGHT 2021 Springer ;Copyright Springer Nature B.V. Nov 2021 ;The Author(s) 2021, corrected publication 2021 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-021-01065-y ;PMID: 34368939Full text available |
|
15 |
Material Type: Article
|
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health SystemPharmacoEconomics, 2018-02, Vol.36 (2), p.239-252 [Peer Reviewed Journal]Springer International Publishing AG 2017 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. Feb 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-017-0585-2 ;PMID: 29273843Full text available |
|
16 |
Material Type: Article
|
Calculating and Interpreting ICERs and Net BenefitPharmacoEconomics, 2020-08, Vol.38 (8), p.785-807 [Peer Reviewed Journal]Springer Nature Switzerland AG 2020 ;COPYRIGHT 2020 Springer ;Copyright Springer Nature B.V. Aug 2020 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00914-6 ;PMID: 32390067Full text available |
|
17 |
Material Type: Article
|
Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for PracticePharmacoEconomics, 2015-12, Vol.33 (12), p.1255-1268 [Peer Reviewed Journal]The Author(s) 2015 ;COPYRIGHT 2015 Springer ;Copyright Springer Science & Business Media Dec 2015 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-015-0309-4 ;PMID: 26105525Full text available |
|
18 |
Material Type: Article
|
Cost-Effectiveness Thresholds: the Past, the Present and the FuturePharmacoEconomics, 2018-05, Vol.36 (5), p.509-522 [Peer Reviewed Journal]Springer International Publishing AG, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Copyright Springer Nature B.V. May 2018 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-017-0606-1 ;PMID: 29427072Full text available |
|
19 |
Material Type: Article
|
ErratumPharmacoEconomics, 2011-12, Vol.29 (12), p.1014 [Peer Reviewed Journal]Copyright Wolters Kluwer Health Adis International Dec 2011 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11598620-000000000-00000Full text available |
|
20 |
Material Type: Article
|
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for OsteoporosisPharmacoEconomics, 2021-02, Vol.39 (2), p.181-209 [Peer Reviewed Journal]The Author(s) 2020 ;COPYRIGHT 2021 Springer ;Copyright Springer Nature B.V. Feb 2021 ;ISSN: 1170-7690 ;ISSN: 1179-2027 ;EISSN: 1179-2027 ;DOI: 10.1007/s40273-020-00965-9 ;PMID: 33026634Full text available |